Gene · 7364
Papers2,547
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 2,547
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Physiologically-Based Pharmacokinetic Modeling of Fluconazole Using Plasma and Cerebrospinal Fluid Samples From Preterm and Term Infants. | CPT Pharmacometrics Syst Pharmacol | 2019 | 31087536 | PubTator, text mining | PubMed |
| Associations between UGT2B7 polymorphisms and cancer susceptibility: A meta-analysis. | Gene | 2019 | 31082503 | PubTator, text mining | PubMed |
| The Influence of Race, Ethnicity and Genetic Variants on Postoperative Pain Intensity: An Integrative Literature Review. | Pain Manag Nurs | 2019 | 31080143 | PubTator, text mining | PubMed |
| Comparative analysis of myometrial and vascular smooth muscle cells to determine optimal cells for use in drug discovery. | Pharmacol Res | 2019 | 31078743 | PubTator, text mining | PubMed |
| A marijuana-drug interaction primer: Precipitants, pharmacology, and pharmacokinetics. | Pharmacol Ther | 2019 | 31071346 | PubTator, text mining | PubMed |
| The Fusarium metabolite culmorin suppresses the in vitro glucuronidation of deoxynivalenol. | Arch Toxicol | 2019 | 31049613 | PubTator, text mining | PubMed |
| Could Postnatal Age-Related Uridine Diphosphate Glucuronic Acid Be a Rate-Limiting Factor in the Metabolism of Morphine During the First Week of Life? | CPT Pharmacometrics Syst Pharmacol | 2019 | 31044547 | PubTator, text mining | PubMed |
| Glomerular Filtration Rate Is a Major Predictor of Clearance of Oxcarbazepine Active Metabolite in Adult Chinese Epileptic Patients: A Population Pharmacokinetic Analysis. | Ther Drug Monit | 2019 | 31033858 | PubTator, text mining | PubMed |
| Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz-Containing Antiretroviral Therapy. | Clin Pharmacol Ther | 2019 | 31006110 | PubTator, text mining | PubMed |
| Application of a physiologically based pharmacokinetic model for the prediction of mirabegron plasma concentrations in a population with severe renal impairment. | Biopharm Drug Dispos | 2019 | 30985942 | PubTator, text mining | PubMed |
| Investigation of the absolute bioavailability and human mass balance of navoximod, a novel IDO1 inhibitor. | Br J Clin Pharmacol | 2019 | 30973970 | PubTator, text mining | PubMed |
Physicochemical Properties, Biotransformation, and Transport Pathways of Established and Newly Approved Medications: A Systematic Review of the Top 200 Most Prescribed Drugs vs. the FDA-Approved Drugs Between 2005 and 2016. | Clin Pharmacokinet | 2019 | 30972694 | PubTator, text mining | PubMed |
| Recent progress and challenges in screening and characterization of UGT1A1 inhibitors. | Acta Pharm Sin B | 2019 | 30972276 | PubTator, text mining | PubMed |
| Mining Featured Biomarkers Linked with Epithelial Ovarian CancerBased on Bioinformatics. | Diagnostics (Basel) | 2019 | 30970615 | PubTator, text mining | PubMed |
| Major glucuronide metabolites of testosterone are primarily transported by MRP2 and MRP3 in human liver, intestine and kidney. | J Steroid Biochem Mol Biol | 2019 | 30959153 | PubTator, text mining | PubMed |
| Differences in the rate of nicotine metabolism among smokers with and without HIV. | AIDS | 2019 | 30946162 | PubTator, text mining | PubMed |
| Investigation of the Endoplasmic Reticulum Localization of UDP-Glucuronosyltransferase 2B7 with Systematic Deletion Mutants. | Mol Pharmacol | 2019 | 30944207 | PubTator, text mining | PubMed |
| Pharmacokinetic and Pharmacogenetic Factors Contributing to Platelet Function Recovery After Single Dose of Ticagrelor in Healthy Subjects. | Front Pharmacol | 2019 | 30936830 | PubTator, text mining | PubMed |
| Pharmacogenomic considerations for antiplatelet agents: the era of precision medicine in stroke prevention and neurointerventional practice. | Cold Spring Harb Mol Case Stud | 2019 | 30936195 | PubTator, text mining | PubMed |
| Targeting the ERK Signaling Pathway in Melanoma. | Int J Mol Sci | 2019 | 30934534 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7364/papers?page=50